Press Release Press Release: Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease 3 hours ago
Press Release Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded Jul 29